Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma
International Journal of Molecular Sciences · 14.07.2026 · 27 (14) · 6273
DOI: 10.3390/ijms27146273 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.07.2026. Verfasst von Adam Piecuch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowi…. Hauptthemen laut MEDLINE: Adenocarcinoma, N-Acetylglucosaminyltransferases, Colonic Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.
Abstract (Originalsprache)
Aberrant glycosylation contributes to tumour progression and metastatic dissemination. Beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) is involved in poly-N-acetyllactosamine synthesis, but its role in colon adenocarcinoma remains insufficiently characterised. This retrospective single-centre study evaluated B3GNT3 expression and its association with clinicopathological parameters using TCGA and CPTAC data, immunohistochemistry in 97 colon adenocarcinomas, Western blot analysis, and transmission electron microscopy. TCGA analysis showed no significant differences in B3GNT3 mRNA expression between normal and tumour tissues. In contrast, CPTAC, immunohistochemistry, and Western blot analyses demonstrated increased B3GNT3 protein expression in tumour tissue compared with non-neoplastic mucosa. Immunohistochemical expression was assessed semi-quantitatively using the immunoreactive score (IRS). Lower B3GNT3 expression was associated with advanced stage and node-positive status. Because pathological stage and lymph node status are interrelated clinicopathological variables in colon adenocarcinoma, these findings were interpreted as partially overlapping associations rather than independent biological endpoints. Exploratory ROC and logistic regression analyses supported these cohort-level associations; however, the ROC-derived IRS cut-off was not externally validated, and regression models were interpreted cautiously. TEM/immunogold analysis supported Golgi/secretory-pathway localisation but was descriptive. Overall, B3GNT3 expression was associated with clinicopathological features in this retrospective cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Department of General and Bariatric Surgery and Emergency Medicine in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
- Department of Medical Genetics, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
ORCID-Profile: Karolina Bajdak-Rusinek, Marek Michalski, Marlena Brzozowa-Zasada
Förderung
- Medical University of Silesia
Zitieren
APA
Piecuch, A., Piecuch, J. Z., Bajdak-Rusinek, K., Michalski, M., Matysiak, N., & Brzozowa-Zasada, M. (2026). Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma. International Journal of Molecular Sciences, 27(14), 6273. https://doi.org/10.3390/ijms27146273
Vancouver
Piecuch A, Piecuch JZ, Bajdak-Rusinek K, Michalski M, Matysiak N, Brzozowa-Zasada M. Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma. International Journal of Molecular Sciences. 2026;27(14):6273. doi:10.3390/ijms27146273
BibTeX
@article{Piecuch2026,
author = {Piecuch, Adam and Piecuch, Jerzy Z and Bajdak-Rusinek, Karolina and Michalski, Marek and Matysiak, Natalia and Brzozowa-Zasada, Marlena},
title = {Association of B3GNT3 Expression with Tumour Stage and Lymph Node Metastasis in Colon Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6273},
doi = {10.3390/ijms27146273}
}
EUVIMED